The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless merchandise represents a substantial regulatory obstacle with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at large dosages6. The promises created by Nicotine River, ECBlend, and various vendors that